Global Markets
thumbnail
Global MarketsBIOSECURE and Catalent deal could bag more biz for ThermoBIOSECURE and Catalent deal could bag more biz for Thermo
Thermo Fisher Scientific highlighted the BIOSECURE Act and the pending Catalent/Novo deal as potential drivers for its CDMO business during its Q1 earnings call.